We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.06%
5 Year Est. Return
+670.57%
10 Year Est. Return
–
AUM
$851M
AUM Growth
-$105M
Cap. Flow
+$44.2M
Cap. Flow %
5.19%
Top 10 Hldgs %
47.53%
Holding
835
New
170
Increased
157
Reduced
172
Closed
270

Top Buys

Rank Stock Value
1
KVSC
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
+$24.3M
2
STOK icon
Stoke Therapeutics
STOK
+$22.8M
3
TIOA
Tio Tech A Class A Ordinary Share
TIOA
+$22.1M
4
SCPH
scPharmaceuticals
SCPH
+$20.6M
5
AAC
Ares Acquisition Corporation
AAC
+$13.3M

Top Sells

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.8M
2
SCPL
SciPlay Corporation Class A Common Stock
SCPL
+$25.2M
3
CTLP
Cantaloupe
CTLP
+$12.3M
4
INVZ icon
Innoviz Technologies
INVZ
+$10.9M
5
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
+$8.76M

Sector Composition

Rank Sector Weight
1 Healthcare 38.46%
2 Financials 25.66%
3 Materials 12.69%
4 Consumer Discretionary 4.54%
5 Technology 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLVM icon
1
Sylvamo
SLVM
$1.49B
$99.5M 11.68%
2,150,000
– –
RNAM
2
DELISTED
Avidity Biosciences
RNAM
$70.5M 8.28%
4,592,966
+304,600
+7% +$6.7M
ESTA icon
3
Establishment Labs
ESTA
$2.72B
$58.7M 6.89%
866,172
+9,518
+1% +$653K
AVDL
4
DELISTED
Avadel Pharmaceuticals
AVDL
$34.2M 4.02%
3,732,778
– –
STOK icon
5
Stoke Therapeutics
STOK
$1.8B
$27.3M 3.21%
3,279,142
+2,531,065
+338% +$22.8M
SCPH
6
DELISTED
scPharmaceuticals
SCPH
$25.5M 2.99%
+2,807,562
New +$20.6M
KVSC
7
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$24.5M 2.87%
+2,410,664
New +$24.3M
SMFG icon
8
Sumitomo Mitsui Financial
SMFG
$164B
$22.4M 2.63%
2,800,730
-570,000
-17% -$4.82M
TIOA
9
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
$22.2M 2.6%
+2,176,071
New +$22.1M
IMCR icon
10
Immunocore
IMCR
$1.72B
$20M 2.35%
405,174
– –
IMVT icon
11
Immunovant
IMVT
$7.93B
$19.4M 2.28%
1,250,000
– –
RCKT icon
12
Rocket Pharmaceuticals
RCKT
$340M
$18.8M 2.21%
1,100,000
– –
ACET icon
13
Adicet Bio
ACET
$85.2M
$18.1M 2.13%
196,476
– –
ET icon
14
Energy Transfer Partners
ET
$70.1B
$17.3M 2.03%
1,384,500
-330,500
-19% -$4.18M
INVZ icon
15
Innoviz Technologies
INVZ
$95M
$16.4M 1.93%
4,696,109
-2,460,281
-34% -$10.9M
PEGR
16
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$15.3M 1.8%
1,500,000
– –
HCVIU
17
DELISTED
Hennessy Capital Investment Corp. VI Unit
HCVIU
$15.2M 1.79%
1,500,000
– –
CCV
18
DELISTED
Churchill Capital Corp V
CCV
$14.1M 1.65%
1,397,140
+1,248,295
+839% +$12.5M
AAC
19
DELISTED
Ares Acquisition Corporation
AAC
$13.5M 1.58%
+1,304,228
New +$13.3M
CVII
20
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$12.5M 1.46%
1,227,823
+942,823
+331% +$9.48M
SILJ icon
21
Amplify Junior Silver Miners ETF
SILJ
$3.18B
$11.9M 1.4%
1,072,434
+437,805
+69% +$4.63M
CUTR
22
DELISTED
Cutera, Inc.
CUTR
$11.6M 1.36%
491,512
-179,797
-27% -$5.75M
COIN icon
23
Coinbase
COIN
$38.5B
$9.04M 1.06%
133,846
+97,371
+267% +$5.83M
ODP
24
DELISTED
ODP
ODP
$8.96M 1.05%
199,181
-5,000
-2% -$244K
MSOS icon
25
AdvisorShares Pure US Cannabis ETF
MSOS
$858M
$8.92M 1.05%
1,568,280
+244,936
+19% +$1.62M
1
2 3 4 5

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2023 Portfolio in Review

As of Q1 2023, Cowen and Company held 835 positions worth $851M, down 11% from $956M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Cowen and Company deployed $44.2M of net new capital in Q1 2023, opening 170 new positions and adding to 157 existing holdings. Its largest new stake was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was SciPlay Corporation Class A Common Stock, an estimated $25.2M trimmed.

  • Cowen and Company's largest Q1 2023 buy was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.
  • Cowen and Company added most to Stoke Therapeutics in Q1 2023, an estimated $22.8M increase.
  • Cowen and Company's biggest Q1 2023 reduction was SciPlay Corporation Class A Common Stock, cutting an estimated $25.2M.
  • Cowen and Company fully exited DCP Midstream, LP in Q1 2023, selling an estimated $58.8M.
  • Cowen and Company's ten largest holdings make up 48% of its $851M portfolio in Q1 2023.
  • Cowen and Company opened 170 new positions and closed 270 in Q1 2023.
  • Cowen and Company's portfolio value fell 11% quarter-over-quarter to $851M.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.